Flow cytometry demonstrated a typical immunophenotype for RUNX1::RUNX1T1 AML, and RT-PCR confirmed the fusion transcript. Initial treatment with azacitidine and venetoclax was initiated without bone ...

Flow cytometry–triggered genomic testing and automation reduced turnaround times for AML diagnostics, enhancing personalized therapy and patient care. The initiative involved clinician education ...

Expert Rev Mol Diagn. 2012;12(5):511-526. Qualitative end-point RT-PCR can be used for minimal residual disease (MRD) monitoring, [36] but has been largely overtaken by quantitative techniques ...

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese ...